Source: https://www.cori-clinical.com/ AI for clinical trials # Run any trial with a lean team. For sponsors and CROs. Cori Clinical builds the living blueprint of your clinical trial, bringing together your organisation's knowledge, enriched by trusted external information sources. Cori helps teams turn an initial trial brief into a full protocol, submission package and operational plans. Cori is AI-guided: it drafts, the clinical team decides. [Book a demo](https://www.cori-clinical.com/contact) [I'm a sponsor Leaner team, faster to first participant in](https://www.cori-clinical.com/sponsors) [I'm a CRO Price on precedent, defend every change order](https://www.cori-clinical.com/cros) - ISO/IEC 27001 certified - GxP aligned - Hosted in your region Prefer to browse? [Cori for sponsors](https://www.cori-clinical.com/sponsors) or [Cori for CROs](https://www.cori-clinical.com/cros). The living blueprint ## Clinical and commercial teams work from one versioned record of the trial. Change the design: the budget, the bid and the documents follow it, with nothing re-typed. Finished trials stay on record, so the next one starts from them. Trial 4 in progress · modules in any order · 3 past trials in the blueprint Reads the record Decision record Your data External, included with Cori Your data - Protocols - Past trials - Budgets and bids - SOPs and templates - 1 Feasibility and strategy Scenarios and strategy - 2 Design and schedule Schedule of Assessments - 3 Trial risks Risk register - 4 Bid and budget Site budget or priced bid - 5 Regulatory package Protocol and country packs - 6 Compliance review Findings and sign-off External regulatory intelligence Included with Cori - Curated trial registries - Regulatory guidance - Regulatory findings - Trial legislation Guidance from EMA, FDA, MHRA and ICH [See how it works](https://www.cori-clinical.com/platform) What changes ## See the cost and the gaps before the trial starts. - ### Design and cost Without Cori Complexity is discovered during conduct, and cost is worked out separately. With Cori Design options compared on duration, cost and site burden. The budget is projected from the Schedule of Assessments and moves when the design changes. - ### Execution Without Cori Word docs, email threads and meetings drive decisions. The protocol "looks done" but ops details are unresolved. With Cori Protocol, ICF, operational plans and country packs drafted from the same living blueprint, with gaps named early. - ### Your experience Without Cori What past trials taught you stays with the people who ran them. With Cori Your past protocols, budgets and decisions are there for the next trial, alongside trusted external sources. - ### New guidance Without Cori Regulatory updates are checked by hand against each document. With Cori When guidance changes, Cori flags the risks and decisions that matter for your trial. - ### Your team Without Cori Headcount grows with the portfolio. With Cori A lean team runs the trial and makes the decisions. [Book a demo](https://www.cori-clinical.com/contact) Who it is for ## Sponsors run leaner. CROs bid on evidence. For sponsors ### Run leaner and keep control. - Do more with the team you have Cori drafts protocols, consent forms and amendments from your own documents. - Fewer review cycles before first participant in A design change carried into every document in one pass. - See every decision Each one saved with its evidence and the person who approved it. [Cori for sponsors](https://www.cori-clinical.com/sponsors) For CROs ### Defend the bid, keep the margin. - Bids you can defend Every line priced on trials you delivered, with the comparable trials behind it. - Margin you keep Scope change caught when it happens and turned into a change order, before it becomes unbillable. - Startup you can predict Risks named from comparable trials while there is still time to act. [Cori for CROs](https://www.cori-clinical.com/cros) ## One system for accelerating clinical trials: turning study insight and organisational experience into a living blueprint of the trial [Book a demo](https://www.cori-clinical.com/contact) --- Source: https://www.cori-clinical.com/platform How it works # The living blueprint of your clinical trial. Cori reads your protocols, RFPs and past trials into one versioned record, the Knowledge Hub, enriched with trusted external sources. Feasibility, design, risks, the bid and budget, submissions and review all work from it, before the trial starts and while it runs, and each saves its decision back. [Book a demo](https://www.cori-clinical.com/contact) [See the modules](https://www.cori-clinical.com/platform#modules) - ISO/IEC 27001 certified - GxP aligned - Hosted in your region ## Knowledge Hub Mapped to CDISC USDM v4.0. - Feasibility and strategy Scenario chosen - Design and SoA Design chosen - Trial risks Owners set - Bid and budget Budget agreed - Regulatory package Drafting - Compliance review Next Each module reads what the others decided, in any order, and saves its own decision back. The modules ## Every module starts from what the others already decided. - [Feasibility and strategy](https://www.cori-clinical.com/platform#feasibility) - [Design and SoA](https://www.cori-clinical.com/platform#design) - [Trial risks](https://www.cori-clinical.com/platform#risks) - [Bid and budget](https://www.cori-clinical.com/platform#bid) - [Regulatory package](https://www.cori-clinical.com/platform#package) - [Compliance review](https://www.cori-clinical.com/platform#review) - [Amendments](https://www.cori-clinical.com/platform#amendments) - [Decision records](https://www.cori-clinical.com/platform#decisions) Feasibility and strategy Where and how ### Build the strategy on what comparable trials did. The challenge Country and site choices often rest on a few people's memory of past trials, and the evidence behind a strategy is hard to show to the sponsor or the rest of the team. Cori drafts the ways the trial could run and scores each against comparable trials, yours and those in curated registries. Sample study What it changes - #### Scenario planning Several ways the trial could run, side by side. - #### Your ideas, tested the same way Describe a change in plain words. The original stays, and your variant is scored against the same evidence. - #### A strategy you can defend Each score shows the trials behind it, and says so when there are none. Design and SoA What to run ### Design the trial you can deliver. The challenge Designs are usually judged on the science first. Their cost, duration and burden on sites and participants show up later, when they are expensive to change. Compare design options on duration, cost and site burden, not only on endpoints. Sample study What it changes - #### Fewer surprises later Recruitment, startup time and outcomes from registries and your own delivered trials. - #### Cost and burden, seen while it is still a choice Duration, visits per participant, cost and endpoint risk, side by side. - #### One schedule, everything follows Edit the visit grid in place. The budget and the documents follow it. Trial risks What could go wrong ### See the risks before you commit. The challenge Risk registers are often filled in from experience and revisited rarely, so a risk is found when it lands rather than while there is time to plan around it. Each risk is scored on how often it appeared in comparable trials, when it landed and what it cost. Sample study What it changes - #### Risks found while there is time to act Each risk comes with how it played out on comparable trials, yours or public ones. - #### Scores you can trace Likelihood and impact come from comparable trials and regulatory findings. - #### Flagged again when things change Each risk has an owner and a plan. When the design or the regulations change, Cori flags the risks that change with them. Bid and budget What it costs ### A budget that moves when the design does. The challenge Bids are priced under time pressure from spreadsheets and memory, and each line is hard to defend when the sponsor pushes back. The site budget is projected from the Schedule of Assessments. CROs price each bid line on trials they delivered, with public benchmarks where their own data is thin. Sample study What it changes - #### Bids you can defend Each bid price shows the comparable trials it came from. - #### Per site and per country Site and country budgets are broken out from the same schedule. - #### Every negotiation round kept Each round is a snapshot, so you can show what changed and why. FSP bids Dedicated roles ### CROs price dedicated roles on their own grades. When a CRO places dedicated staff with a sponsor, Cori reads the sponsor's job descriptions and maps each role to the CRO's grades, with its reasoning shown. The rate card by role and country is built from its grade cost bands and checked against the rates it won at, restated to today's terms, with lost bids alongside. Sample study What it changes - #### Graded on scope A Site Manager role with Senior CRA scope is graded and priced for that scope, so the rate matches the work asked for. - #### Contract terms in the margin The escalator, USD rates with no FX clause, and vacancy and backfill cost, each shown in contribution margin before the bid goes out. - #### Past bids, with the debrief Each bill rate sits beside the FSP rates won and lost before, with the sponsor's debrief attached. Regulatory package Protocol to country packs ### The package for every country, from one blueprint. The challenge Every country needs its own documents and translations, all consistent with the protocol. Keeping them aligned by hand is slow, and gaps are often found late. Cori drafts the protocol on your templates, then the consent form, submission documents and each country's pack, and names the gaps while there is time to close them. What it changes - #### Protocol first, everything consistent Drafted from the design, the schedule and the decisions already made, with the consent form and submission documents kept consistent with it. - #### Every country covered The local documents each country needs, including Part II for each EU member state. - #### Translations that keep their format Each document translated for its country, with structure and formatting kept. Compliance review Against the rules ### Reviewed against your SOPs and the rules that apply. The challenge Reviewers check each document by hand against regulations, guidance and SOPs, and findings live in email threads and tracked changes. Each draft is checked against ICH GCP, the regulations of each trial country, your SOPs and the rest of the record. Findings are pinned to their passage, and nothing moves on until a reviewer signs it off. What it changes - #### Your standards, every time Every draft is checked against your own standards. - #### The rules that apply, checked ICH GCP, the EU Clinical Trials Regulation, FDA regulations and national law in each trial country. - #### Documents that agree with each other Flags where a document disagrees with the design, the schedule or another document. Built into every module ## A change reaches every module, and the reasoning stays. Amendments When it changes ### Change once. See everything it touches. The challenge One amendment can touch many documents, country packs, budget lines and dates. Finding them all by hand is slow, and anything missed becomes rework or unbillable work. Once an amendment is approved, Cori redrafts the affected sections and, for CROs, the change order. What it changes - #### Impact before commitment Every affected document, cost and date, listed before anyone agrees to the change. - #### Redrafted for your review Your team reviews redrafted sections instead of editing each document and country pack by hand. - #### Change orders with evidence Each one carries the design change behind it and comparable changes from your history. Decision records The reasoning ### Each decision is saved with its evidence and the person who approved it. The challenge The reasoning behind a decision usually lives in meeting notes and inboxes, and leaves with the people who made it. Every step records the question, the options considered, the evidence and the approver. What it changes - #### Recorded as you work Captured where the decision is made, with no separate log to keep. - #### Read by every step Budget, documents and review start from the decisions already made. - #### Your organisation's memory The next trial can look up what was decided before and how it turned out. The record itself ## Every value shows where it came from. Each field shows whether a person, a file or Cori supplied it, and earlier versions stay on record. Every field shows the document and section its value came from. The visit grid, edited in place, with a window flagged where it disagrees with the protocol. Where Cori sits ## Works alongside the systems you already run. Your CTMS, RIM, eTMF and document systems stay the systems of record. Cori keeps the blueprint beside them, with every value traced to its source. Your systems of record - CTMS - RIM - eTMF - Document systems Cori, alongside them The living blueprint of the trial, with its drafts and decisions. They stay as they are. Nothing to replace. Your data, your decisions ## Your trial runs in its own environment. ### Your own environment Each customer has its own deployment, hosted in its region. Your data is never used to train models. ### Cori drafts, a person decides Nothing is applied until someone approves it. When Cori cannot find a source, it asks. ### Every value traces back Each value shows who supplied it: a person, a file or Cori. Earlier versions too. ### Certified, and every action logged ISO/IEC 27001 certified, with EU, US and UK data residency. An altered log entry shows. [Security and compliance](https://www.cori-clinical.com/security) ## See what it changes for your team. [I'm a sponsor Leaner team, faster to first participant in](https://www.cori-clinical.com/sponsors) [I'm a CRO Price on precedent, defend every change order](https://www.cori-clinical.com/cros) ## See it on a trial of your own. Book a demo with us. [Book a demo](https://www.cori-clinical.com/contact) --- Source: https://www.cori-clinical.com/sponsors Cori for sponsors # A small team, running the study like a large one. Design, documents, submissions and amendments work from the living blueprint of your clinical trial, enriched with trusted external sources. Cori drafts and checks. Your team decides. [Book a demo](https://www.cori-clinical.com/contact) [See it at work](https://www.cori-clinical.com/sponsors#each-step) - ISO/IEC 27001 certified - GxP aligned - Hosted in your region What changes ## One copy of each document to chase. Every decision on record. - ### Modifications/Amendments Without Cori Each document re-edited by hand, and one copy gets missed. With Cori Everything the change touches is listed before you commit, then the affected sections are redrafted. - ### Oversight Without Cori Decisions buried in email threads. With Cori Each decision saved with its evidence and the person who approved it. - ### Team Without Cori Headcount grows with the portfolio. With Cori A lean team runs the trial. A suggested edit arrives with the passage it was drawn from, and your reviewer answers it in the same place. Design to amendment ## Decide once, and the rest follows. Design and cost ### See what a design costs while it is still a choice Compare options on duration, cost and site burden. The budget is projected from the Schedule of Assessments and moves when the design does. Sample study Regulatory package ### Every country pack drafted from the same protocol The consent form, synopsis and country packs follow the protocol, and gaps are named while there is time to close them. Modifications/Amendments ### Change it once, and see everything it touches first Before you commit, Cori lists every document, budget line and date the amendment affects. Once it is approved, Cori redrafts them. [See how it works in full](https://www.cori-clinical.com/platform) Oversight ## A record you can hand an inspector. ### It asks instead of inventing When Cori cannot ground a section in your sources, it asks the person who knows. ### Every action logged If a log entry is ever altered, it shows. The same fact, checked across every document that states it, and re-checked whenever any of them changes. ## In only thirty minutes See what a leaner trial looks like on your own study. [Book a demo](https://www.cori-clinical.com/contact) --- Source: https://www.cori-clinical.com/cros Cori for CROs # Win the bid. Keep the margin. Repeat the business. Behind every bid deadline is a team defending a proposal built in days. Behind every stalled modification, patients wait. Cori turns your organisation's precedent knowledge into a living blueprint for trial startup, one shared source for bid and clinical-ops teams, less searching, more strategy. Trials move faster. Patients wait less. [Book a demo](https://www.cori-clinical.com/contact) [See what changes](https://www.cori-clinical.com/cros#what-you-get) - ISO/IEC 27001 certified - GxP aligned - Hosted in your region What you get ## Every trial you deliver makes the next bid stronger. ### A bid sponsors can check Each price and date shows the trials behind it, so sponsor procurement sees the reasoning, not only the number. ### Trial startup you can predict Risks named from past trials while there is time to act, so first participant in (FPI) dates rest on evidence. ### No system to replace Cori works alongside your CTMS, RIM and eTMF. They stay the systems of record. An RFP read into fields, each showing the page it came from, with the open questions above the drafted answers. What changes ## Price on evidence. Bill every change. - ### Bids Without Cori Priced from a spreadsheet and whoever remembers a similar trial. With Cori Every line priced on comparable trials you delivered, with external benchmarks where your own data is thin. - ### Scope change Without Cori Found after delivery and absorbed as unbillable work. With Cori Caught when the design changes, with the change order drafted alongside the change that caused it. - ### What you learned Without Cori Stays with the team that ran the trial. With Cori Every past bid, decision and amendment is there for the next one. In the product ## The number you quoted is the number you deliver on. ### Know which risks are coming before you sign Each risk is scored against your past trials: how often it appeared, when it landed and what it cost. The mitigation and its owner are set before the bid defence. Your delivery data stays in your deployment and is never used to train models. Sample study ### Defend every change order When a sponsor asks for a change, Cori shows everything it touches, from protocol to budget, and prices it against similar changes you have delivered. The budget is projected from the Schedule of Assessments, so the price moves when the design does. [See bid, budget and change orders](https://www.cori-clinical.com/platform#bid) Every scope change with the change that drove it, what it is worth, and where it stands. FSP bids ## Price dedicated roles on your own grades. Cori reads the sponsor's job descriptions, places each role on your own job architecture with the reasoning shown, and flags titles that would be mis-graded. Every bill rate is checked against the rates you have won at, restated to today's terms, with lost bids alongside. - A rate card by role and country, built from your grade cost bands and billable hours, never from individual salaries - The escalator, FX terms, and vacancy and backfill cost shown in your margin before the bid goes out [See how FSP pricing works](https://www.cori-clinical.com/platform#fsp) Sample study ## See your next bid priced on work you have delivered. Thirty minutes, on a bid like one you have run. [Book a demo](https://www.cori-clinical.com/contact) --- Source: https://www.cori-clinical.com/security Security and compliance # Your trial data stays isolated, and stays yours. Your own private instance, in your own region. Access is by role, and nothing you put in is used to train a model. [Book a demo](https://www.cori-clinical.com/contact) [Report a security issue](mailto:security@cori-clinical.com) EU, US and UK data residency ## Certifications held ISO/IEC 27001 Certified GDPR Complied with EU AI Act Complied with GxP aligned Complied with The full security posture is documented at trust.cori-clinical.com. Certificates and the current subprocessor list are available under NDA. Ask on the call, or write to security@cori-clinical.com. How it is built ## The controls, group by group. How your data is stored, who can reach it, and what the audit trail says. ### Protection #### Encryption at rest and in transit AES-256 at rest, TLS 1.2 and 1.3 in transit, with keys rotated on a fixed schedule. #### Continuous monitoring Threats, vulnerabilities and anomalies are monitored continuously rather than periodically. ### Access #### Strict access controls Role-based permissions and multi-factor authentication. Access that was refused is logged too, not just access that was granted. #### Regional processing and hosting Processed and hosted in your region. The region is set when your account is created, and support cannot change it. ### Governance #### Data ownership and confidentiality Never used to train models, never shared without consent, reachable on a need-to-know basis. #### Governance you can read off the screen Access, controls and activity across every document and user, without assembling it by hand. Good to know ## The questions procurement asks first. ### Is Cori certified? Cori Clinical holds ISO/IEC 27001 certification and complies with the GDPR and the EU AI Act. The scope covers the design, development and operation of the platform, including customer trial data hosted in the EU, US and UK regions. The full posture, with certificates, lives at trust.cori-clinical.com. ### Where is our trial data hosted? Each customer runs in an isolated deployment, hosted in the EU, the US or the UK. ### Is our data used to train models? No. Customer content is never used to train models, and no model provider retains it. A zero data retention policy applies to every model call the platform makes. ### What does the audit trail cover? Every action is logged, and the log is enforced by the database rather than by the application, so an altered entry shows. Deleting a user does not erase what they did, and access that was refused is logged alongside access that was granted. ### How do we report a security issue? Write to security@cori-clinical.com. Reports are triaged on receipt and acknowledged before any public disclosure is coordinated. ## The full detail, under NDA. Book thirty minutes with us, or write to security@cori-clinical.com and we will take it from there. [Book a demo](https://www.cori-clinical.com/contact) --- Source: https://www.cori-clinical.com/about Why we are building Cori Clinical # Give the time back to the science. Too often, trial teams repeat work their organisation has already done. Disconnected processes, siloed teams and untraced decisions add delays before new treatments reach patients. Clinical trial start-up still relies on fragmented processes and disconnected sources of information, making it difficult for teams to apply relevant precedent and assess the wider implications of early design decisions. The cost of getting those early decisions wrong is significant: Tufts CSDD research found that 76% of protocols are amended,[1](https://www.cori-clinical.com/about#footnote-1) with each substantial amendment carrying direct costs of around $141,000 for a Phase II protocol and $535,000 for Phase III.[2](https://www.cori-clinical.com/about#footnote-2) Amended protocols are also associated with longer recruitment and overall study durations. Researchers set out to advance science, then spend the week carrying each decision by hand into every document it touches. Cori is built to give time back to the science, so no patient waits for science that's ready. 1. 1 Therapeutic Innovation & Regulatory Science. New Benchmarks on Protocol Amendment Practices, Trends and their Impact on Clinical Trial Performance. https://doi.org/10.1007/s43441-024-00622-9. Accessed October 2026. 2. 2 Sage Journals. The Impact of Protocol Amendments on Clinical Trial Performance and Cost. https://journals.sagepub.com/doi/10.1177/2168479016632271. Accessed October 2026. [Book a demo](https://www.cori-clinical.com/contact) [See how it works](https://www.cori-clinical.com/platform) ## Where the time goes Protocol, consent form and budget kept as separate documents One design change re-typed through everything it touches Medical, regulatory and operations working from separate copies Scientific staff spending their weeks on documentation Trial startup taking longer than the science needs About Cori Clinical ## Clinical development deserves better. Behind every clinical trial that starts late, a patient is waiting for the treatment. Cori Clinical is the intelligence layer for accelerating clinical trials, creating a living blueprint of a trial from initial idea through to first participant in. Its unified workspace turns a clinical team's collective insight and organisational experience, enriched with trusted external intelligence, into a single, shared source for all clinical and commercial teams. Cori surfaces and structures the evidence, while clinical teams retain responsibility for judgement and approval. Less time is lost to reconciling data, documents and version conflicts, so more time is available for the decisions that move a trial forward. No patient waits for science that's ready. That's the reason Cori exists. **Jorn & Patricio** Co-founders of Cori Clinical Jorn Jansen Schoonhoven and Patricio Fernandez Weisson, co-founders. ## Investors and advisors - Maarten Alblas Founder, DataSnipper - Ben Peters Founder, Five AI and Cogna - An Van Es-Johansson Chief Medical Officer, Sobi - Tim Shi Founder, Cresta and Early Research, OpenAI - Stan Boland Founder, Icera and FiveAI ## Vision No patient waits for science that's ready. ## Mission One system for accelerating clinical trials: turning study insight and organisational experience into a living blueprint of the trial Leadership ## The people you will work with. - Co-founder & CEO ### Jorn Jansen Schoonhoven Co-Founder and CEO of Cori Clinical, created to bring AI efficiencies to one of healthcare's most outdated workflows: clinical development. He previously led data science teams at Amazon and IBM, where he also served as Chief of Staff for EMEA. After investing in AI startups at Octopus Ventures, he founded Cori to apply what he'd seen work across industries to the critical bottlenecks in clinical trials. - Co-founder & CTO ### Patricio Fernandez Weisson With over 10 years of experience in AI and previously Data Science Director at Evinova (AstraZeneca), and Lead Data Scientist at Sanofi. He started Cori Clinical after seeing firsthand how much time and talent is wasted on manual, repetitive work in clinical trials, and how little of AI's potential is reaching the people who need it. Cori is his way of fixing that: practical AI tools, built for the teams that need it the most. - Chief Clinical Officer ### Emma Ogburn, PhD 20+ years of experience in global clinical trials with industry, academia, all trial types, phases and therapeutic areas. Emma has scaled a number of organisations, most notably University of Oxford CTU (leading the UK Government's National COVID-19 trials), Cancer Research UK Trial Acceleration and most recently a tech-enabled CRO, Lindus Health. Passionate about using tech and novel methods to get treatments to patients faster. FAQ ## Good to know. ### What is Cori, and how does it help clinical trial teams? Cori Clinical is an AI workspace which brings together the knowledge an organisation has developed through years of clinical trial experience and combines it with external intelligence from clinical-trial registries, regulatory guidance and public sources including Food and Drug Administration (FDA), Medicines and Healthcare Products Regulatory Agency (MHRA) and European Medicines Agency (EMA). Cori helps clinical teams turn an initial trial brief into a full protocol, submission package and operational plans, built against current regulatory guidance. Rather than addressing a single document or workflow, Cori helps teams build and maintain a living blueprint for a feasible and executable trial. As new guidance is published, Cori builds it into the workspace and flags the risks and decisions that matter for a trial's success. This enables teams to test proposed designs against both their own experience and the wider evidence base, identify risks, assess options and connect study-design decisions with budgets, timelines and operational plans. Cori's AI surfaces and structures the evidence, while clinical teams retain responsibility for judgement and approval. Less time is lost to reconciling data, documents and version conflicts, so more time is available for the decisions that move a trial forward. Cori works with biotechs, CROs and research institutions, backed by operators in life sciences and AI, to help clinical teams move faster, stay aligned and raise quality without compromising compliance. So no patient waits for science that's ready. ### Which types of clinical trial documents does Cori support? Across the documentation of trial startup, with each artefact kept consistent with the others: - Study protocols and protocol amendments - Investigator brochures - Informed consent forms (ICFs) - Case report forms (CRFs) - Clinical study reports (CSRs) - Common Technical Document (CTD) modules for regulatory submissions - Site and sponsor communications ### How does Cori integrate with existing workflows and systems? Cori fits the processes you already run: - Flexible document import and export, working with Word, PDF and regulatory submission formats - Microsoft Word add-in, so you can edit documents directly with Cori - Collaboration tools to assign tasks, track changes and manage approvals within your team ### How does Cori help with regulatory requirements? Cori is built to align with FDA, EMA, ICH-GCP and local requirements. It pulls the relevant guidance for each document, flags missing elements, and shows where the protocol and the participant-facing materials disagree. The judgement belongs to your regulatory team; Cori shows them what to look at. Cori Clinical holds ISO/IEC 27001 certification and complies with the GDPR and the EU AI Act. HIPAA is supported under a Business Associate Agreement, and 21 CFR Part 11 support is in progress. ### Is Cori secure, and how is data protected? Yes. The controls that back that up: - AES-256 encryption at rest, TLS 1.2 and 1.3 in transit - None of your data is used to train models, under a zero data retention policy - Role-based permissions to restrict document access - Audit logs, so every action is tracked and attributable - Cloud infrastructure monitored continuously for threats and anomalies ### How can I try Cori or request a demo? [Book a demo](https://www.cori-clinical.com/contact) and we will walk through the platform on your own study, not a sample one. ## Happy to go deeper on any of this. Book thirty minutes with us. [Book a demo](https://www.cori-clinical.com/contact) --- Source: https://www.cori-clinical.com/contact Contact us # In only thirty minutes We will walk through the platform on a study of your own, so you see how it fits your team. ## Or reach us directly - General enquiries: [info@cori-clinical.com](mailto:info@cori-clinical.com) - Technical support: [support@cori-clinical.com](mailto:support@cori-clinical.com) - Security issues: [security@cori-clinical.com](mailto:security@cori-clinical.com) - Phone: [+44 7522 819365](tel:+447522819365) Office: Cori Clinical Ltd, Fora, York House, 221 Pentonville Road, London, N1 9UZ, United Kingdom --- Source: https://www.cori-clinical.com/support Support # Stuck? Tell us and we will pick it up. One address for anything that is not working as it should, and a short list of what to send so we can act on it first time. ## How to reach us - Email [support@cori-clinical.com](mailto:support@cori-clinical.com) - Phone [+44 7522 819365](tel:+447522819365) Security issues go to [security@cori-clinical.com](mailto:security@cori-clinical.com) instead, so the right people see them first. ## What to include - Which study, and which part of the platform you were in. - What you expected to happen, and what happened instead. - Roughly when it happened. - Screenshots if you have them, with no participant data in them. Standard support is available during business hours. Anything specific to your agreement is set out in your Order Form. [Or see every way to reach us](https://www.cori-clinical.com/contact) --- Source: https://www.cori-clinical.com/news News # Notes from the team. Company announcements, our point of view on industry news, and what we are learning as we build the living blueprint of your clinical trial. ## Press and media For journalists and analysts Email [info@cori-clinical.com](mailto:info@cori-clinical.com) [Follow us on LinkedIn](https://www.linkedin.com/company/cori-clinical/) ## All posts - Announcement 7 October 2026 ### [Cori Clinical raises $4m seed round to help clinical teams design better trials and reduce costly delays](https://www.cori-clinical.com/news/cori-clinical-raises-4m-seed-round) Funding will accelerate Cori Clinical's product development, expand delivery capacity and support growth across its clinical, engineering and commercial teams, including newly appointed Chief Clinical Officer Dr Emma Ogburn. - Perspective First published 8 July 2025 · revised August 2026 ### [Collaboration, not autonomy](https://www.cori-clinical.com/news/collaboration-not-autonomy-building-ai-for-clinical-development) In clinical development, AI works best when people keep the decisions. How Cori authors trial documents and leaves the judgement with your team. --- Source: https://www.cori-clinical.com/news/cori-clinical-raises-4m-seed-round Announcement # Cori Clinical raises $4m seed round to help clinical teams design better trials and reduce costly delays 7 October 2026 London, 7 October 2026: Cori Clinical, the intelligence layer for accelerating clinical trials, has closed a $4 million seed round led by Breega, with participation from Enzo, Heartfelt, Together Ventures and Bynd. From left: Patricio Fernandez Weisson, co-founder and CTO; Dr Emma Ogburn, Chief Clinical Officer; Jorn Jansen Schoonhoven, co-founder and CEO. The funding will expand Cori's capacity for delivery; support the growth of the team, including the appointment of Chief Clinical Officer [Dr Emma Ogburn](https://www.cori-clinical.com/about#emma-ogburn-phd), who joins from Lindus Health; and deepen the regulatory and clinical intelligence in Cori's platform. It will also enable Cori to build on its customer traction and convert growing interest from clinical research organisations (CROs) and pharmaceutical companies into deeper and broader commercial relationships. Clinical trials still rely on fragmented processes and disconnected sources of information, making it difficult for teams to apply relevant precedent and assess the wider implications of early design decisions. The cost of getting those early decisions wrong is significant: a 2026 Tufts CSDD study found that 76% of protocols are amended, with each substantial amendment carrying direct costs of around $141,000 for a Phase II protocol and $535,000 for Phase III. Amended protocols were also associated with longer recruitment and overall study durations. That is frustrating for everyone involved: CROs trying to run trials effectively and cost-efficiently; sponsors trying to reach 'first participant in' as quickly as possible; and, most importantly, patients waiting for new treatments that depend on a trial starting. Cori Clinical is an AI workspace which brings together the knowledge an organisation has developed through years of clinical trial experience and combines it with external intelligence from clinical-trial registries, regulatory guidance and public sources, including the Food and Drug Administration (FDA), the Medicines and Healthcare products Regulatory Agency (MHRA) and the European Medicines Agency (EMA). Cori helps clinical teams turn an initial trial brief into a full protocol, submission package and operational plans, built against current regulatory guidance. Rather than addressing a single document or workflow, Cori helps teams build and maintain a living blueprint for a feasible and executable trial. As new guidance is published, Cori builds it into the workspace and flags the risks and decisions that matter for a trial's success. This enables teams to test proposed designs against both their own experience and the wider evidence base, identify risks, assess options and connect study-design decisions with budgets, timelines and operational plans. Based on internal modelling using average trial set-up costs, historical modification rates and time to 'first participant in', Cori estimates that its approach could reduce average trial set-up costs by at least 33%. By bringing these inputs and decisions into one connected workspace, Cori is designed to reduce duplicated work and the risk of avoidable rework, cost and delay, while giving clinical teams greater visibility and control. In an internal evaluation benchmarked against amendments from completed trials, Cori's AI reviewer flagged 82% of protocol errors classified as avoidable. Cori Clinical is already working with 2 of the top 5 enterprise CROs globally. In addition, Cori has customers across the clinical development ecosystem, including Erasmus MC, an academic medical centre and university hospital in Rotterdam, where the Cori platform supported two clinical trials in neurosurgery and neuro-oncology. Dr Judith Verhagen-Oldenampsen, Research Coordinator, Neurosurgery Dept, Erasmus MC, said: “What normally takes us several months to draft, the protocol and Investigator Brochure, we completed in a matter of weeks. Beyond the speed, Cori has genuinely added value in the earliest stages of trial design, helping us pressure-test ideation and answer design questions we would otherwise have debated internally for far longer. For a unit running complex oncology and neurosurgery trials, that combination of speed, scientific rigour and responsiveness has added great value.” [Jorn Jansen Schoonhoven](https://www.cori-clinical.com/about#jorn-jansen-schoonhoven), Co-Founder and CEO of Cori Clinical, said: “Clinical trials are built through a series of interconnected decisions about how a study should be designed and run. Today, much of the knowledge and precedent behind those decisions is scattered across previous trials, siloed teams, internal systems and separate documents. Cori brings that intelligence together into a living blueprint, so teams can make better-informed decisions before avoidable problems become delays, so the science never waits on the process.” Matthieu Vallin, Partner at Breega, which led the funding round, said: “Clinical trial start-up is a critical but often overlooked bottleneck in drug development, with months lost between designing a trial and enrolling the first patient. Cori is bringing the intelligence and connected workflows needed to make that process faster, and we're excited to back Jorn, Patricio and Emma and the team as they bring this powerful capability to more trials.” Edgar Vicente, Founding Partner at Enzo Ventures, added: “Clinical trials are moving from fragmented documents to structured, machine-readable systems. Cori is building the source of truth underneath that shift, led by a team that has lived the pain firsthand and has exceptional founder-market fit. We believe they can become a core infrastructure layer for how trials are designed and run.” Dr Emma Ogburn, who joins the Cori Clinical team as Chief Clinical Officer, has seen the problem of long trial start-up timelines first-hand. At Cancer Research UK, she helped bring new investigational products for blood cancers into clinical trials faster, reducing a six-month timeline by one-third. At the University of Oxford, she led the UK's national urgent public health programme, helping deliver trials of potential COVID-19 treatments to more than 41,000 patients, with trial start-up reduced to two weeks while maintaining regulatory compliance. After Oxford, Emma went on to scale Lindus Health from the ground up, resulting in a global tech-enabled CRO, where she was able to significantly compress trial timeframes across the entire trial lifecycle. Dr Ogburn says: “Trial technology has changed little in the past two decades, but recent progress in AI and large language models has opened a compelling path forward in bringing greater efficiency to trials and their lead times. Cori Clinical brings clinical and regulatory intelligence into one connected workspace, while keeping expert judgement at the centre. I'm excited to help more teams put this approach into practice and reduce the time between a promising idea and a trial that is ready to start.” Cori was founded by Jorn Jansen Schoonhoven (CEO) and [Patricio Fernández](https://www.cori-clinical.com/about#patricio-fernandez-weisson) (CTO). Jorn's background spans AI and data science, including roles at Amazon and IBM working on supply-chain systems, robotics and life-sciences applications. Patricio brings experience from the pharmaceutical industry, where he led data science at both Sanofi and AstraZeneca. ## About Cori Clinical Behind every clinical trial that starts late, a patient is waiting for a treatment. Cori Clinical is the intelligence layer for accelerating clinical trials, creating a living blueprint of a trial from initial idea through to execution. Its unified workspace turns a clinical team's collective insight and organisational experience, enriched with trusted external intelligence, to help teams identify risks, assess options and connect study design with the practical requirements of running a trial. Cori surfaces and structures the evidence, while clinical teams retain responsibility for judgement and approval. Less time is lost to reconciling data, documents and version conflicts, so more time is available for the decisions that move a trial forward. No patient should have to wait when the science is ready but the process is too slow. Sources - [Tufts CSDD: New Benchmarks on Protocol Amendment Practices, Trends and their Impact on Clinical Trial Performance, Therapeutic Innovation & Regulatory Science (2024)](https://doi.org/10.1007/s43441-024-00622-9) - [Tufts CSDD: The Impact of Protocol Amendments on Clinical Trial Performance and Cost, Therapeutic Innovation & Regulatory Science (2016)](https://journals.sagepub.com/doi/10.1177/2168479016632271) [All news](https://www.cori-clinical.com/news) ## See it on a study of your own. Book a demo with us. [Book a demo](https://www.cori-clinical.com/contact) --- Source: https://www.cori-clinical.com/news/collaboration-not-autonomy-building-ai-for-clinical-development Perspective # Collaboration, not autonomy By [Patricio Fernandez Weisson](https://www.cori-clinical.com/about#patricio-fernandez-weisson), Co-founder & CTO First published 8 July 2025 · revised August 2026 AI does not need to run on its own to be worth building. In clinical development, it should not. Clinical development is full of ambiguity, trade-offs, political dynamics, and knowledge that never gets written down. So Cori is AI-guided. It authors the documents and surfaces the decisions, and the team decides. The system provides the speed; the people keep the judgement. ## Where the chaos actually comes from The chaos in clinical development comes from fragmented information. The people are not the problem. Documents live in different places. Prior decisions get buried. Two people reference different versions of the same file without knowing it. Small misalignments compound into costly delays. That is the coordination Cori is built for: helping a team work from one base of structured, verified information. Cori flags contradictions and surfaces missing context, and it brings past decisions back into view when they matter again. It does not make the calls. When the trade-off is participant burden against data quality, or speed against regulatory risk, that takes human judgement. Strategy and precedent do not follow clean rules, and neither does politics. And much of what matters is not written down anywhere. A method you remember working once before, a site you have heard struggles with participant engagement, a reviewer who prefers data laid out a particular way. Software cannot intuit any of that. What it can do is keep the written record in one place and flag where it has drifted, so your judgement stands on solid ground. ## What AI brings to the surface What AI can do is bring the key decisions to the surface, so clinicians, regulators and operators decide with the context in front of them instead of hunting for it. The biggest risks in clinical development come from blind spots: trade-offs made without context, inconsistencies nobody noticed, assumptions nobody stated. Take the protocol. Authoring one involves hundreds of interdependent decisions about eligibility criteria, endpoints, assessments and regulatory strategy. AI can surface relevant past trials, suggest accepted standards, and flag gaps and inconsistencies. It cannot decide which trade-offs suit a specific therapeutic area, or how far a sponsor's risk appetite stretches. It can help you decide. It cannot decide for you. ## From tool to teammate This split has already been tested in diagnosis. In a randomised trial published in npj Digital Medicine, clinicians and a customised GPT each made an independent diagnostic assessment, and the AI then combined the two, marking where they agreed, where they differed, and commenting on each. Clinicians working this way reached 85% diagnostic accuracy when the AI gave the first opinion and 82% when it gave the second, against 75% for clinicians using conventional resources. The fine print matters. The AI on its own scored highest of all, at 87%. But the cases were clinical vignettes, short structured reports of a patient's history and findings, the kind a student doctor meets in an exam. Real patients and their problems are messier. That is where human expertise still holds the edge. In radiology, the pattern reported is that AI performs well on large-scale image analysis while humans remain better on the edge cases involving ambiguity, context or prior experience. The reliable gains come from working with AI as a collaborator rather than a replacement. ## How Cori works with you The workflow we are building follows the same shape. Cori does not start generating a document the moment you ask for one. It works out what the document needs, then checks that against what you actually have. Where something required is missing, Cori flags the gap and prompts you for the additional information before drafting. Once the gaps are closed, Cori authors the document and your team reviews it and decides. That back and forth is the point. The system moves fast precisely because it stops to ask. ## The judgement stays with your team Humans stay in the loop because there is a great deal they do better than machines. The useful question is how AI and people work together to improve decisions, and through them, outcomes for participants. Let AI handle the organising and the repetitive work, so people spend their time where their experience counts: the strategic and political calls, and the messy real-world edge cases. AI should fit into the way your team already works. Sources - [From tool to teammate: a randomised controlled trial of clinician-AI collaborative workflows for diagnosis. npj Digital Medicine, 2026](https://www.nature.com/articles/s41746-026-02545-1) - [Full text with the results detail, PubMed Central](https://pmc.ncbi.nlm.nih.gov/articles/PMC12155023/) [All news](https://www.cori-clinical.com/news) ## See it on a study of your own. Book a demo with us. [Book a demo](https://www.cori-clinical.com/contact) --- Source: https://www.cori-clinical.com/events/scope SCOPE Europe 2026 · Barcelona # The Ever Changing Order of Stories in Clinical Trials over cocktails and mocktails Bring your best story about a study that changed after it was designed. We'll bring the drinks. No slides, no pitches, just people who design, plan, run and price trials, swapping notes at a bar in Sant Antoni. [Walking directions](https://www.google.com/maps/dir/?api=1&origin=InterContinental%20Barcelona%2C%20Av.%20de%20Rius%20i%20Taulet%201-3%2C%20Barcelona&destination=Rosa%20Barcelona%2C%20Carrer%20de%20Floridablanca%2088%2C%2008015%20Barcelona&travelmode=walking) Protocol CORI-SCOPE-26 Admit one Version 1.0 · amendments expected Visit date Tuesday 13 October 2026 Visit window 17:30 to 19:00ish Site **Rosa Barcelona** Carrer de Floridablanca, 88, 08015 Barcelona Getting there About 15 minutes on foot from the InterContinental Barcelona (Fira Center) Primary endpoint Good conversation Exclusions Slides, pitches, anyone who says “quick question” about a budget Take it with you Scan to open the walk on your phone. The walk ## From the conference to the cocktails, _dot by dot_ - Start: InterContinental Barcelona, Av. de Rius i Taulet, 1-3 - Finish: Rosa Barcelona, Carrer de Floridablanca, 88 - Cori will be there, waving Head north from the hotel, cross Avinguda del Paral·lel, and walk up into Sant Antoni. Rosa is on Carrer de Floridablanca, a couple of blocks from the Mercat de Sant Antoni. Map not to scale, unlike our budgets. The site ## Rosa Barcelona, _Sant Antoni_ > “Llegas por una copa, te quedas toda la noche.” > > Rosa's own promise: you come for one drink, you stay all night. - What: Cocktail bar with signature cocktails, natural and conventional wines from Catalonia, Spain and France, and homemade tapas with vegetarian options - Address: Carrer de Floridablanca, 88, 08015 Barcelona - Open: Tuesdays 17:00 to 19:00ish - Website: [rosabarcelonabar.com](https://www.rosabarcelonabar.com/) Signature cocktails, many of them pink Toasts under the golden lamp Patatas valientes and homemade tapas Natural wines from Catalonia, Spain and France Illustrations by Cori. For the real thing, see the photos on [rosabarcelonabar.com](https://www.rosabarcelonabar.com/). Schedule of Assessments ## The plan, _subject to amendment_ | Time | Visit | What happens | | -------- | ----------- | ---------------------------------------------------------------------- | | 17:30 | Visit 1 | First guest in. Walk over from the InterContinental, follow the dots. | | 17:45 | Visit 2 | First round. Cocktails, mocktails or a glass of something natural. | | 18:15 | Deviation | Someone mentions change orders. We let it happen. | | 18:40 | Amendment 1 | “One more” is added to the schedule. Nobody files the paperwork. | | 19:00ish | Soft lock | Officially, the end. Rosa is open until 23:00, and nobody is counting. | Icebreakers, fully sourced ## Why the order of stories _keeps changing_ 76% of protocols needed at least one substantial amendment. Mean of 3.3 substantial amendments per amended protocol, up 60% in seven years. 260 days on average from amendment need to the last oversight approval. Sites run mixed protocol versions for about 215 days. Source: Tufts CSDD, 2022 data on about 950 protocols, in Getz K, [“Shining a light on the inefficiencies in amendment implementation”](https://appliedclinicaltrialsonline.com/view/shining-a-light-on-the-inefficiencies-in-amendment-implementation), Applied Clinical Trials, 6 December 2023. ## Coming? _Tell us._ A quick reply helps us save you a seat and a glass. Tell whoever from Cori invited you, or drop the team a line. Bring a colleague who has a good amendment story. [lucy@cori-clinical.com](mailto:lucy@cori-clinical.com) **Hosted by Cori Clinical** The intelligence layer for accelerating clinical trials --- Source: https://www.cori-clinical.com/legal/terms Legal # Terms of Service Last updated: August 2025 These Terms of Service govern access to and use of the Cori Clinical platform and related websites, applications, APIs, and documentation (the Service) provided by Cori Clinical Ltd (Cori, we, us, our). Cori Clinical Ltd is a company registered in England and Wales. Company number: 16115688. Registered address: Fora, York House, 221 Pentonville Road, London, N1 9UZ, United Kingdom By creating an account, clicking to accept, or using the Service, you agree to these Terms. If you are using the Service on behalf of an organisation, you represent and warrant that you have authority to bind that organisation. You and any organisation you represent are collectively the Customer. These Terms form a binding contract between Cori and Customer. If you do not agree, do not use the Service. ## On this page 1. [1. Definitions](https://www.cori-clinical.com/legal/terms#1-definitions) 2. [2. Eligibility and Accounts](https://www.cori-clinical.com/legal/terms#2-eligibility-and-accounts) 3. [3. Access to the Service](https://www.cori-clinical.com/legal/terms#3-access-to-the-service) 4. [4. Customer Data and Privacy](https://www.cori-clinical.com/legal/terms#4-customer-data-and-privacy) 5. [5. Third Party Services](https://www.cori-clinical.com/legal/terms#5-third-party-services) 6. [6. Support and Availability](https://www.cori-clinical.com/legal/terms#6-support-and-availability) 7. [7. Fees and Payment](https://www.cori-clinical.com/legal/terms#7-fees-and-payment) 8. [8. Confidentiality](https://www.cori-clinical.com/legal/terms#8-confidentiality) 9. [9. Intellectual Property](https://www.cori-clinical.com/legal/terms#9-intellectual-property) 10. [10. Term and Termination](https://www.cori-clinical.com/legal/terms#10-term-and-termination) 11. [11. Warranties and Disclaimers](https://www.cori-clinical.com/legal/terms#11-warranties-and-disclaimers) 12. [12. Indemnity and Liability](https://www.cori-clinical.com/legal/terms#12-indemnity-and-liability) 13. [13. Compliance](https://www.cori-clinical.com/legal/terms#13-compliance) 14. [14. Changes](https://www.cori-clinical.com/legal/terms#14-changes) 15. [15. Publicity](https://www.cori-clinical.com/legal/terms#15-publicity) 16. [16. General](https://www.cori-clinical.com/legal/terms#16-general) 17. [17. Contact](https://www.cori-clinical.com/legal/terms#17-contact) 18. [18. Country Specific Terms](https://www.cori-clinical.com/legal/terms#18-country-specific-terms) ## 1. Definitions Affiliate means an entity that directly or indirectly controls, is controlled by, or is under common control with a party. Confidential Information means non public information disclosed by one party to the other in connection with the Service that is designated as confidential or that should reasonably be understood to be confidential. Customer Data is Confidential Information of Customer. Customer Data means data, content, documents, files, prompts, outputs, metadata, and other information submitted to or generated in the Service by or on behalf of Customer, including Personal Data. Documentation means Cori manuals, help articles, and policies published at or linked from cori-clinical.com. Order Form means an ordering document, online checkout, or other agreement that specifies the Service plan, quantities, and pricing purchased by Customer. Personal Data means information relating to an identified or identifiable natural person and has the meaning given in applicable Data Protection Laws. Service Data means data generated by the Service about configuration, logs, telemetry, and usage that does not include Customer Data except in aggregated or de identified form. Subprocessor means a third party engaged by Cori to process Customer Data to provide the Service. Subscription Term means the period specified in the Order Form or online plan during which Customer is permitted to use the Service. User means an individual whom Customer authorises to use the Service. ## 2. Eligibility and Accounts The Service is for business use only. Customer is responsible for Users and their compliance with these Terms. Customer must keep account credentials confidential and secure. Customer will notify Cori promptly of any suspected unauthorised access to an account. ## 3. Access to the Service 3.1 Right to Use. Subject to these Terms and timely payment of fees, Cori grants Customer a limited, non exclusive, non transferable right to access and use the Service during the Subscription Term for Customer's internal business purposes. 3.2 Acceptable Use. Customer will not and will ensure Users do not: (a) copy, modify, or create derivative works of the Service, (b) reverse engineer or attempt to extract source code except to the extent such restriction is prohibited by law, (c) interfere with or disrupt the Service, (d) use the Service to violate law, infringe rights of others, or transmit malicious code, (e) use the Service to process unlawful or high risk content, including content that is illegal, harmful, or discriminatory, (f) resell, lease, lend, or provide the Service to third parties, or (g) access the Service to build a competing product. Cori may suspend access if Customer breaches this Section or poses a security risk. Cori will provide notice where practicable. 3.3 Beta and Evaluation Features. Cori may offer features identified as beta, preview, early access, or evaluation. These features are provided for evaluation without service level commitments and may be changed or discontinued at any time. ## 4. Customer Data and Privacy 4.1 Ownership. As between the parties, Customer retains all rights, title, and interest in and to Customer Data. Cori does not claim ownership of Customer Data. 4.2 Licence to Provide the Service. Customer grants Cori and its subprocessors a worldwide, limited licence to host, copy, process, transmit, and display Customer Data to provide, secure, support, and improve the Service in accordance with these Terms and the Data Processing Addendum. Cori will not use Customer Data for advertising or to train foundation models that are not dedicated to Customer, unless expressly agreed in writing. 4.3 Privacy Policy. Cori will process Personal Data in accordance with the Privacy Policy at which is incorporated by reference. 4.4 Data Processing Addendum. Where Customer Data includes Personal Data and Cori acts as a processor, the parties agree to the Data Processing Addendum (DPA) available at which is incorporated by reference and includes the EU Standard Contractual Clauses and the UK International Data Transfer Addendum where applicable. 4.5 Security. Cori will maintain administrative, physical, and technical safeguards designed to protect Customer Data that are appropriate to the nature of the data and risks of processing. These measures include access controls, encryption in transit and at rest, logging, vulnerability management, and regular security reviews. Additional information is available in the Trust Center at . 4.6 Incident Notification. Cori will notify Customer without undue delay after confirming a Security Incident that results in accidental or unlawful destruction, loss, alteration, unauthorised disclosure of, or access to Customer Personal Data. Cori will provide information reasonably available to assist Customer with legal or contractual notification duties. Cori will investigate and take reasonable steps to mitigate harmful effects. 4.7 Data Location and Transfers. Cori may process Customer Data in the United Kingdom, the European Economic Area, and other jurisdictions in which Cori or its subprocessors operate. Cross border transfers will be made under an adequate safeguard, such as the EU Standard Contractual Clauses and the UK International Data Transfer Addendum, where applicable. 4.8 Subprocessors. Customer authorises Cori to use subprocessors to provide the Service. Cori will impose data protection obligations on subprocessors that provide a level of protection for Customer Data that is materially no less protective than Cori's obligations under these Terms and the DPA. A current list of subprocessors is available in the Trust Center. 4.9 Data Retention and Deletion. During the Subscription Term Customer may export Customer Data via available tools or APIs. Upon termination or expiry of the Subscription Term, Customer may request export of Customer Data for thirty days. After that period Cori may delete or anonymise Customer Data unless law requires retention. Cori may retain Service Data for security, compliance, and accounting purposes. 4.10 Medical Information. The Service is not intended to provide medical advice and is not a medical device. Customer is solely responsible for decisions made in clinical or regulatory contexts. Customer must implement appropriate human review and validation for outputs generated by the Service. ## 5. Third Party Services The Service may interoperate with third party products or services. Third party terms and privacy policies govern Customer's use of those products. Cori is not responsible for third party products and does not control changes to their functionality, pricing, or availability. ## 6. Support and Availability 6.1 Support. Cori provides standard support to Customer during business hours as described at or in an Order Form. Customer must provide reasonable cooperation and information to resolve issues. 6.2 Availability. Cori aims to provide reliable Service availability. Planned maintenance that is expected to cause material downtime will be scheduled outside of core business hours where practicable and announced in advance via the status page or in product notice. Cori may perform emergency maintenance at any time to address security or stability issues. ## 7. Fees and Payment 7.1 Fees. Customer will pay the fees set out in the applicable Order Form or online plan. Unless stated otherwise, fees are in euros, exclude taxes, and are non refundable except where required by law. 7.2 Invoicing and Payment. Fees are due as stated in the Order Form or at checkout. If undisputed amounts are more than fifteen days overdue Cori may suspend the Service until paid. Late amounts may accrue interest at the lesser of 1.5 percent per month or the maximum rate permitted by law. Customer is responsible for applicable taxes, excluding taxes based on Cori's net income. 7.3 Changes. For renewals of online plans, Cori may change pricing by providing at least thirty days notice prior to the end of the current Subscription Term. ## 8. Confidentiality Each party will use the other party's Confidential Information only to exercise rights and perform obligations under these Terms and will protect it using reasonable care. Confidential Information does not include information that is publicly known without breach, was known to the receiving party without confidentiality obligations, is independently developed, or is rightfully received from a third party. The receiving party may disclose Confidential Information if required by law, after giving reasonable notice to the disclosing party where lawful. ## 9. Intellectual Property 9.1 Service IP. Cori and its licensors retain all rights, title, and interest in and to the Service and Documentation, including any improvements, modifications, or derivative works. No rights are granted to Customer except as expressly set out in these Terms. 9.2 Feedback. If Customer provides ideas, suggestions, or feedback, Cori may use them without restriction and without obligation to Customer. 9.3 Outputs. Subject to these Terms and applicable law, Cori assigns to Customer all of Cori's rights in outputs that are generated by the Service from Customer inputs, to the extent such outputs are capable of ownership. Cori may use outputs in aggregated or de identified form to operate and improve the Service. ## 10. Term and Termination 10.1 Term. These Terms start on the date Customer first accepts them and continue for the Subscription Term and any renewals. 10.2 Renewal. Subscriptions renew automatically for the same period unless either party gives notice of non renewal at least thirty days before the end of the current Subscription Term or as otherwise stated in the Order Form. 10.3 Termination for Cause. Either party may terminate these Terms for material breach if the breach is not cured within thirty days after written notice. Cori may terminate immediately for breach of Section 3.2 or for unlawful use of the Service. 10.4 Effect of Termination. Upon termination or expiry Customer will stop using the Service and pay any amounts due. Sections intended to survive will survive, including Sections 4, 5, 7, 8, 9, 10.4, 11, and 12. Data export and deletion rights are described in Section 4.9. ## 11. Warranties and Disclaimers 11.1 Mutual Warranties. Each party represents that it has the right, power, and authority to enter into these Terms. 11.2 Service Warranty. Cori warrants that during the Subscription Term the Service will perform in all material respects as described in the Documentation. Customer's exclusive remedy for breach of this warranty is for Cori to use reasonable efforts to correct the non conformity or, if Cori cannot do so within a reasonable time, Customer may terminate the affected portion of the Service and Cori will refund prepaid fees for the unused remainder of the Subscription Term. 11.3 Disclaimers. Except as stated in Section 11.2, the Service and Documentation are provided as is. Cori disclaims all warranties, express or implied, including warranties of merchantability, fitness for a particular purpose, non infringement, and accuracy. Cori does not warrant that the Service will be error free or uninterrupted. 11.4 High Risk Use. The Service is not designed for use in life support, emergency services, or other high risk activities where failure could lead to death, personal injury, or severe environmental or property damage. ## 12. Indemnity and Liability 12.1 IP Indemnity by Cori. Cori will defend Customer against any third party claim that the Service, when used as permitted under these Terms, directly infringes a patent, copyright, or trademark, or misappropriates a trade secret, and will pay amounts finally awarded by a court or agreed in settlement. Cori's obligations do not apply to claims arising from Customer Data, third party products, combinations not supplied by Cori, or Customer's breach of these Terms. If the Service is or is likely to be enjoined, Cori may, at its option, modify the Service, procure a licence, or terminate the affected Service and refund prepaid fees for the unused remainder of the Subscription Term. 12.2 Indemnity by Customer. Customer will defend Cori against claims arising from Customer Data or Customer's use of the Service in breach of these Terms or law, and will pay amounts finally awarded by a court or agreed in settlement. 12.3 Limitation of Liability. To the maximum extent permitted by law, neither party will be liable for indirect, incidental, special, consequential, or punitive damages, or for loss of profits, revenue, data, or goodwill, even if advised that such damages are possible. Except for payment obligations, breach of confidentiality, or a party's indemnification obligations, each party's total aggregate liability under these Terms is limited to the fees paid or payable by Customer to Cori for the Service that gave rise to the liability in the twelve months before the event giving rise to liability. 12.4 Nothing in these Terms limits liability for death or personal injury caused by negligence, fraud, fraudulent misrepresentation, or any other liability that cannot be limited by law. ## 13. Compliance 13.1 Data Protection. Each party will comply with applicable Data Protection Laws. The DPA governs processing of Personal Data where Cori acts as a processor. 13.2 Export and Sanctions. Customer represents that it is not subject to sanctions and will comply with export control and sanctions laws. Customer will not use the Service in prohibited countries or for prohibited end uses. 13.3 Healthcare Laws. Cori is not a covered entity or business associate under HIPAA unless the parties have entered into a Business Associate Agreement. If Customer requires HIPAA obligations, the parties must execute a BAA before Customer uploads Protected Health Information. ## 14. Changes 14.1 Changes to the Service. Cori may improve or modify the Service. Cori will not materially reduce core functionality during a Subscription Term without providing reasonable notice to Customer. 14.2 Changes to these Terms. Cori may update these Terms. For material changes, Cori will provide notice by email or in product and the changes will take effect at the start of the next renewal Subscription Term. Changes for legal, safety, or security reasons may take effect sooner. ## 15. Publicity Cori may identify Customer as a customer and use Customer's name and logo in accordance with Customer's brand guidelines in marketing materials and on our website. Customer may opt out by notifying Cori at any time. ## 16. General 16.1 Governing Law and Venue. These Terms are governed by the laws of England and Wales. The courts of England and Wales will have exclusive jurisdiction. The United Nations Convention on Contracts for the International Sale of Goods does not apply. 16.2 Notices. Notices must be in writing and are deemed given when sent by email to the email address on file for the account or otherwise provided in an Order Form. Legal notices to Cori must be sent to [legal@cori-clinical.com](mailto:legal@cori-clinical.com) with a copy to the registered address. 16.3 Assignment. Neither party may assign these Terms without the other party's consent, except that either party may assign to an Affiliate or in connection with a merger, acquisition, or sale of substantially all assets, provided the assignee agrees in writing to be bound by these Terms. 16.4 Force Majeure. Neither party is liable for failure or delay to perform due to events beyond its reasonable control, including acts of God, internet failures, labour disputes, or government actions. 16.5 Severability. If any provision is held unenforceable, it will be modified to the minimum extent necessary to make it enforceable and the remaining provisions will remain in effect. 16.6 No Waiver. Failure to enforce a provision is not a waiver of the right to enforce it later. 16.7 Entire Agreement. These Terms, the Order Form, the DPA, and the Privacy Policy are the entire agreement between the parties regarding the Service and supersede all prior or contemporaneous agreements on the subject. 16.8 Order of Precedence. If there is a conflict, the following order applies: Order Form, DPA, these Terms, Documentation. ## 17. Contact For questions about these Terms, contact [support@cori-clinical.com](mailto:support@cori-clinical.com) or write to Cori Clinical Ltd at the registered address above. ## 18. Country Specific Terms If Customer is located outside the United Kingdom, additional or different terms may apply to reflect local law. Cori may publish country specific terms at terms which will apply to the extent of any conflict with these Terms. --- Source: https://www.cori-clinical.com/legal/privacy Legal # Privacy Policy Last updated: April 2025 Cori Clinical takes the security of your data and our infrastructure very seriously. We are committed to providing an environment that is safe, secure, and available to all of our customers all the time. Cori Clinical Ltd. ("us," "we," or "our") is committed to protecting your privacy. This Privacy Policy describes how we collect, use, disclose, and protect your personal information. By using our website or services, you consent to the practices described in this Privacy Policy. ## On this page 1. [1. Information We Collect](https://www.cori-clinical.com/legal/privacy#1-information-we-collect) 2. [2. How We Use Your Information](https://www.cori-clinical.com/legal/privacy#2-how-we-use-your-information) 3. [3. Disclosure of Your Information](https://www.cori-clinical.com/legal/privacy#3-disclosure-of-your-information) 4. [4. Third-Party Links](https://www.cori-clinical.com/legal/privacy#4-third-party-links) 5. [5. Security](https://www.cori-clinical.com/legal/privacy#5-security) 6. [6. Your Choices](https://www.cori-clinical.com/legal/privacy#6-your-choices) 7. [7. Changes to This Privacy Policy](https://www.cori-clinical.com/legal/privacy#7-changes-to-this-privacy-policy) 8. [8. Contact Us](https://www.cori-clinical.com/legal/privacy#8-contact-us) ## 1. Information We Collect We may collect the following types of information: a. Personal Information - Name - Email address - Phone number - Postal address - Other information you provide b. Non-Personal Information - IP address - Browser type - Operating system - Referring website c. Cookies We may use cookies to enhance your user experience. You can set your browser to refuse cookies or to alert you when cookies are being sent. ## 2. How We Use Your Information We may use your information for the following purposes: - To provide and maintain our services - To process transactions - To send updates and promotional materials - To improve our services - To monitor and analyze usage patterns ## 3. Disclosure of Your Information We may disclose your information to third parties under the following circumstances: - With your consent - To comply with legal obligations - To protect our rights and interests ## 4. Third-Party Links Our website may contain links to third-party websites. We are not responsible for the content or privacy practices of these websites. We encourage you to review their privacy policies. ## 5. Security We take reasonable measures to protect your information from unauthorized access, disclosure, alteration, or destruction. However, no data transmission over the internet or wireless network can be guaranteed to be 100% secure. ## 6. Your Choices - You can review and update your personal information by contacting us. - You can opt out of receiving promotional emails by using the unsubscribe link provided in those emails. ## 7. Changes to This Privacy Policy We may update this Privacy Policy from time to time to reflect changes to our practices or for other operational, legal, or regulatory reasons. The revised policy will be posted on our website. ## 8. Contact Us If you have any questions about this Privacy Policy, please contact us at [privacy@cori-clinical.com](mailto:privacy@cori-clinical.com).